The outbreak of the SARS-CoV-2 virus caused a sudden shift in focus for the pharmaceutical industry. After the genetic sequence of the virus was released in early 2020, manufacturers across the globe...
This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola. At Q2 Solutions, we support infectious disease clinical trials with a...
Q2 Solutions’ infectious disease expertise, coupled with that of parent organizations IQVIA and Quest Diagnostics, offers extensive diagnostic testing experience, global CRO expertise and multiple...
